Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.46 USD | +1.82% | +1.50% | -13.55% |
11:25am | India's Alembic Pharma posts higher Q4 profit on strong N.America sales | RE |
05-07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.55% | 88.52B | |
+32.81% | 698B | |
+26.51% | 568B | |
-4.58% | 358B | |
+19.59% | 328B | |
+3.54% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.97% | 165B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Jefferies Adjusts Bristol-Myers Squibb Price Target to $54 From $56, Keeps Hold Rating